BiTing-SCLC: Discovery and validation of novel immunotherapeutic treatments specific for SCLC
Aim of the project
BiTing-SCLC will identify tumour targets and develop synergistic combinations of biespecific antibodies. SCLC has the worst prognosis among lung cancer and lacks effective therapies, posing a significant burden for society. BiTing-SCLC addresses these challenges, bringing hope for patients.
